Review of malaria risk and prevention for use in corporate travel.
Malaria continues to be a significant, life-threatening illness in many parts of the world. For corporate travelers from countries with low endemicity, the risk of infection is considerable. Many corporate travelers are unaware of their risk, unsure of the correct preventative measures, and receive incorrect advice regarding prevention or do not comply with advice they have received. This review addresses the risk of malaria to the nonimmune corporate traveler, disease transmission, and recommended means of prevention, including prevention of mosquito bites and antimalaria chemoprophylaxis.
Hymel
Pamela
P
Occupational and Environmental Health Foundation, Cisco Systems, 170 West Tasman Drive, San Jose, CA 95134, USA. phymel@cisco.com
Yang
William
W
D000465:Algorithms; D018692:Antimanic Agents / Q000627:therapeutic use*; D018890:Chemoprevention; D003132:Commerce; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007302:Insect Repellents / Q000627:therapeutic use; D008288:Malaria / Q000517:prevention & control* / Q000635:transmission; D012306:Risk; D014195:Travel
D018692:Antimanic Agents; D007302:Insect Repellents